NewLab BioQuality is a service provider of quality control analysis for biopharmaceutical drugs. The broad-based technologies as well as the company’s commitment to customer satisfaction has demonstrated to many clients that NewLab is a reliable partner for the biopharmaceutical industry. The services are internationally recognised, are GLP or GMP-compliant, and satisfy the regulatory authorities worldwide.

The company provides services ranging from cell bank testing, viral and TSE safety studies as well as characterization of the final product itself, lot release testing and stability studies.  NewLab's modern laboratories are located in Germany in Erkrath and in Cologne.  The company currently employs a multidisciplinary team of more than 130 individuals. In 2005 NewLab BioQuality  acquired Analysis GmbH in Cologne, a leading contract service organization dealing with viral safety of plasma-derived and biopharmaceutical products.

As a provider of contract quality control services using standard as well as innovative methods, NewLab BioQuality can minimize the time it takes to get into clinical trials.
 

NewLab BioQuality is focused on:

• Effective process development for new biotech products 
• Comprehensive integrated processes to shorten the developmental phases of biopharmaceuticals
• High-quality individual customer care and a close interdisciplinary cooperation of project teams